TP53 and lymphoma: MMRi62 induces MDM4 degradation in leukemia/lymphoma cells in an MDM2-dependent manner but p53-independent manner (Figures 3C and S3C), which is consistent with MMRi6’s ability to preferentially promote MDM4 ubiquitination in vitro (Figures 1 and 3).